Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

AHA expresses concern regarding recent action taken by three major drug manufacturers – Eli Lilly and Co., Merck and Sanofi – to limit the distribution of certain 340B drugs to our hospital members.
AHA urges the Centers for Medicare & Medicaid Services to continue its suspension of medical review activities throughout the ongoing COVID-19 public health emergency.
Six national organizations representing hospitals, including the AHA, urge the Centers for Medicare & Medicaid Services to delay the start of repayments associated with the Medicare Accelerated and Advance Payment Programs.
Thirteen organizations representing health care providers, including the AHA, voiced support for the Value in Health Care Act, legislation to strengthen Medicare’s value-based payment models and accountable care organizations.
Congress should allocate as part of the next COVID-19 relief package at least an additional $100 billion to the emergency relief fund to provide direct funding to front line health care personnel and providers, the AHA, American Medical Association and American Nurses Association wrote today to Senate leaders.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,000 health care leaders who belong to our professional membership groups, the American Hospital Association (AHA) appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ (CMS) proposed regulation related to supporting Medicaid drug value-based purchasing (VBP) arrangements and other changes to the Medicaid drug rebate program.
America’s hospitals and health systems, physicians and nurses urge Senators. Mitch McConnell and Charles E. Schumer to include in the next COVID-19 relief bill provisions to strengthen the federal response for racial and ethnic minority and marginalized communities, which are disproportionately affected by the pandemic.
AHA letter to Rep. Mike Thompson expressing support for the Critical Access Hospital Expansion Act (H.R. 6693), legislation that would reopen the “necessary provider” designation to eligible rural hospitals.
AHA comments on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system proposed policy changes and fiscal year 2021 rates.
AHA comments on the Centers for Medicare & Medicaid Services’ long-term care hospital prospective payment system proposed policy changes and fiscal year 2021 rates.